Emergent BioSolutions Newsroom

Rodman & Renshaw Reiterates Buy on Emergent BioSolutions, Maintains $16 Price Target

BenzingaSep 13 23:49

Emergent BioSolutions Analyst Ratings

BenzingaSep 13 23:48

Emergent Biosolutions Price Target Announced at $16.00/Share by Rodman & Renshaw

Dow JonesAug 23 01:38

Rodman & Renshaw Initiates Coverage On Emergent BioSolutions With Buy Rating, Announces Price Target of $16

BenzingaAug 23 01:29

Emergent BioSolutions Analyst Ratings

BenzingaAug 23 01:28

Rodman & Renshaw Upgrades Emergent BioSolutions(EBS.US) to Buy Rating, Cuts Target Price to $16

Futu NewsAug 22 19:33

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaAug 16 21:45

Emergent BioSolutions Analyst Ratings

BenzingaAug 16 21:44

Emergent BioSolutions Analyst Ratings

BenzingaAug 10 00:43

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaAug 10 00:42

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaJul 3 21:50

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaJul 2 22:46

Emergent BioSolutions Analyst Ratings

BenzingaJul 2 22:45

Emergent BioSolutions Analyst Ratings

BenzingaJun 24 23:15

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaJun 24 23:14

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaJun 21 21:20

Emergent BioSolutions Analyst Ratings

BenzingaJun 20 19:38

Benchmark: Reiterates the Emergent BioSolutions (EBS.US) rating and adjusted from buy to buy, with a target price of $5.00.

Zhitong FinanceApr 11 21:10

Emergent BioSolutions Analyst Ratings

BenzingaApr 11 21:05

Analysts' Top Healthcare Picks: Emergent Biosolutions (EBS), Vera Therapeutics (VERA)

TipRanksApr 11 19:25